Today I’m joined by Jonathan Wolf, the co-founder and CEO of ZOE — a personalized nutrition company.
In this episode, we talk about the gut microbiome, at-home test kits, and how ZOE helps people understand the impact different foods have on their well-being. We also discuss the benefits and challenges of a direct-to-consumer model versus seeking FDA approval for companies in the health diagnostic or wearables space.
More from Jonathan
Jonathan is the co-founder of health technology company ZOE. ZOE teaches you how your own body responds to food, based on personalized tests, AI and the largest in-depth nutritional study in the world carried out with Mass General Hospital, Stanford Medicine and King’s College London. He is also the cofounder of ZOE’s COVID Symptom Study, the largest study of COVID in the world with over 4 million users. The study is now funded by the UK government and provides real-time monitoring of COVID cases, support for vaccine trials and crucial scientific research with KCL such as papers in Nature Medicine on which symptoms predict COVID, the importance of anosmia and the first systematic study of long COVID.
Previously he was Chief Product Officer at Criteo which was a 30 person start-up when he joined. Seven years later when he left it was public on NASDAQ, with over 2,000 people and over $1Bn revenue of revenue. In that time Jonathan built the product organization, created the publisher and midmarket sales organization, and opened the New York office. Prior to this Jonathan worked at Yahoo!
Jonathan attended Oxford University where he received the Gibbs prize for Physics and was President of the Oxford Union, and was then at Harvard. He has been a Foundation Fellow at Corpus Christi College Oxford since 2015.
More from Fitt Insider
Fitt Insider is a platform for entrepreneurs, executives, and investors redefining the business of fitness and wellness.
From our newsletter and podcast to our industry-specific jobs board, we create content and resources to drive the industry forward. We also invest in early-stage health and fitness companies.
Learn more here.